[CIS-PAGID] IVIG replacement according to body weight?

Church, Joseph JChurch at chla.usc.edu
Fri May 11 20:49:59 EDT 2012


Bodo: This reference will add to the list of publications that I use to "discuss" IVIG dosing with insurance payors. JC

-----Original Message-----
From: pagid-bounces at list.clinimmsoc.org [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Nelson, Robert P Jr
Sent: Friday, May 11, 2012 3:54 PM
To: 'pagid at list.clinimmsoc.org'
Subject: Re: [CIS-PAGID] IVIG replacement according to body weight?

Bodo, thx very much. Bob

Robert P. Nelson Jr., MD
Professor of Medicine and Pediatrics
Divisions of Hematology/Oncology
535 Barnhill Dr. Ste 473
Indianapolis, IN  46202
Telephone: 317-948-1186
E-mail: ronelson at iupui.edu
pager: 317-312-1773

-----Original Message-----
From: pagid-bounces at list.clinimmsoc.org [mailto:pagid-bounces at list.clinimmsoc.org] On Behalf Of Grimbacher, Bodo
Sent: Friday, May 11, 2012 6:41 PM
To: pagid at list.clinimmsoc.org
Subject: Re: [CIS-PAGID] IVIG replacement according to body weight?

Dear all,
were you aware of this paper?
see attachmentŠ
Yours, Bodo

Centre of Chronic Immunodeficiency
Director
79108 Freiburg, GERMANY


Am 11.05.12 23:28 schrieb "Nelson, Robert P Jr" unter <ronelson at iupui.edu>:


>Our health system, beginning with the pharmacy branch, is pondering the

>question of whether changing IVIG dosing guidelines from actual to

>ideal body weight would be low hanging fruit for reducing IVIG

>expenditures, without adversely affecting patient care outcomes. Of

>course the initial question is general and not answerable across an

>array of immunodeficiency/autoimmune/neurological conditions. But I

>thought this might be a good group to start with and ask if this

>strategy is being considered elsewhere or if you might have thoughtsŠ..

>

>

>You see, many Hoosiers are large and the savings would be significant.

>

>Bob

>

>

>Robert P. Nelson Jr., MD

>Professor of Medicine and Pediatrics

>Divisions of Hematology/Oncology

>535 Barnhill Dr. Ste 473

>Indianapolis, IN 46202

>Telephone: 317-948-1186

>E-mail:

>ronelson at iupui.edu

>pager: 317-312-1773

>

>

>From: pagid-bounces at list.clinimmsoc.org

>[mailto:pagid-bounces at list.clinimmsoc.org]

>On Behalf Of Nelson, Robert P Jr

>Sent: Friday, May 11, 2012 5:19 PM

>To: 'pagid at list.clinimmsoc.org'

>Subject: Re: [CIS-PAGID] non conditioned BMT in a SCIDs case

>

>

>

>Dr. Mageed,

>

>My opinion is that it is good enough, especially if the Hb and platelet

>counts are normal.

>

>To me, the function is adequate to immunize to live viruses.

>

>If the T cell numbers are stable rather than dropping, I would observe.

>I don¹t think it is important whether the myeloid cells are donor or

>recipient. What you gain with a boost is a minor lymphocyte nudge to

>100%, if she is not there already, and risk graft-versus-host, which

>would subvert the goal of improving reconstitution. I don¹t think that

>the mixed lymphocyte chimerism is the predominate immunophysiological

>influence on the stalled recovery, so that the boost may not even

>provide the hoped for result with respect to increased naïve T cell

>production. The rather tepid production now may improve given more

>time and if the donor is a heterozygote for the unknown molecular

>defect, a boost would not be expected to help.

>

>Where are you getting your TRECs measured, just curious, looking for a

>resource.

>

>Bob

>

>

>

>

>Robert P. Nelson Jr., MD

>Professor of Medicine and Pediatrics

>Divisions of Hematology/Oncology

>535 Barnhill Dr. Ste 473

>Indianapolis, IN 46202

>Telephone: 317-948-1186

>E-mail:

>ronelson at iupui.edu

>pager: 317-312-1773

>

>

>From:pagid-bounces at list.clinimmsoc.org[mailto:pagid-bounces at list.clinim

>mso c.org]On Behalf Of Aly.Mageed at helendevoschildrens.org

>Sent: Friday, May 11, 2012 1:15 PM

>To: pagid at list.clinimmsoc.org

>Subject: Re: [CIS-PAGID] non conditioned BMT in a SCIDs case

>

>

>

>What does the group think of a 4YO with a SCIDs/Omenn¹s with an

>unidentified molecular basis who was transplanted from a full sib

>without conditioning more than 3 years ago? She is doing well

>clinically without serious/unusual infections. However, she has stalled

>in donor chimerism to only 10-14%, her lymphocytes are 96% donor

>(likely 100% if it were very pure without myeloid contamination). Yet,

>she continues with CD3/4/8 lymphopenia (CD3 is 400-1000), mostly

>400-500. Most recent CD4 were 250. CD4RTE 27%, TREC is low at

>280-350 (600-700/million CD3), CD19 last was 300. She is surprisingly

>maintaining her own IgG level 400-500. Despite the lymphopenia, PHA is

>good at 60-70% functionally. She responded well to non live vaccines

>with protective levels against Hep B, DPT and prevnar.

>So the Qs are:

>

>1.

>Is this good enough at this stage since she is clinically well?

>2.

>Could she get live vaccines?

>3.

>Or, Does she need a graft boost?....

>Thanks

>

>Aly Mageed, MD, MBA

>Pediatric Blood & Marrow Transplant

>Helen DeVos Children's Hospital

>aly.mageed at helendevoschildrens.org

>

>

>

>

>

>




---------------------------------------------------------------------
CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain confidential
or legally privileged information. Any unauthorized review, use, disclosure
or distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of this original message.

---------------------------------------------------------------------



More information about the PAGID mailing list